Cambridge and GSK announce new five-year collaboration aiming for improved outcomes for patients with hard-to-treat kidney and respiratory diseases
21 October 2024The ambition of the partnership is to treat immune-related diseases more precisely with existing therapies and to rapidly develop new ones.